Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 4/20 | 0.37 |
| ▸ | PPARA | Q07869 | 4/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9155903 | 0.77 | LMNA (0.38) | MTNR1AMTNR1BLMNAGAACYP1A2 | |
| SCHEMBL7661580 | 0.76 | LTA4H (0.39) | MTNR1AMTNR1BLMNAGAACYP1A2 | |
| SCHEMBL9757439 | 0.74 | LMNA (0.39) | MTNR1AMTNR1BLMNAGAACYP1A2 | |
| SCHEMBL11289603 | 0.73 | CHRM1 (0.37) | MTNR1AMTNR1BLMNAGAACYP1A2 | |
| SCHEMBL8012067 | 0.73 | LTA4H (0.36) | MTNR1AMTNR1BLMNAGAACYP1A2 | |
| SCHEMBL25261859 | 0.73 | LTA4H (0.36) | MTNR1AMTNR1BLMNAGAACYP1A2 | |
| SCHEMBL43675 | 0.73 | MTNR1A (0.42) | MTNR1AMTNR1BLMNAGAACYP1A2 | |
| SCHEMBL7362599 | 0.73 | CA1 (0.37) | MTNR1AMTNR1BGAACYP1A2CYP2C9 | |
| SCHEMBL9353539 | 0.73 | MTNR1A (0.42) | MTNR1AMTNR1BLMNAGAACYP1A2 | |
| SCHEMBL6748173 | 0.73 | TSHR (0.36) | MTNR1AMTNR1BGAACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0320785-A2 | Peptides influencing the activity of the hypophysis of mammalians | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-06-21 | — | — | EP | claimed |
| EP-1691763-A4 | CAB MOLECULES | GENENCOR INT (US) | 2008-03-12 | — | — | EP | disclosed |
| EP-1511861-A4 | METHODS AND COMPOSITIONS FOR MILIEU-DEPENDENT BINDING OF A TARGETED AGENT TO A TARGET | GENENCOR INT (US) | 2007-12-05 | — | — | EP | disclosed |
| EP-1735350-A2 | ANTI-CEA SCFV - BETA-LACTAMASE CONSTRUCTS (CAB MOLECULES) IN ADEPT | GENENCOR INTERNATIONAL, INC. (US) | 2006-12-27 | — | — | EP | disclosed |
| EP-1691763-A2 | CAB MOLECULES | GENENCOR INTERNATIONAL, INC. (US) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005111078-A9 | ANTI-CEA SCFV-BETA-LACTAMASE CONTRUCTS (CAB MOLECULES) IN ADEPT | GENENCOR INT (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1543324-A4 | METHODS AND COMPOSITIONS FOR GRAFTING FUNCTIONAL LOOPS INTO A PROTEIN | GENENCOR INT (US) | 2005-12-14 | — | — | EP | disclosed |
| WO-2005111078-A2 | ANTI-CEA SCFV-BETA-LACTAMASE CONTRUCTS (CAB MOLECULES) IN ADEPT | GENENCOR INTERNATIONAL, INC. (US) | 2005-11-24 | — | — | WO | disclosed |
| WO-2005058236-A2 | CAB MOLECULES | GENENCOR INTERNATIONAL, INC. (US) | 2005-06-30 | — | — | WO | disclosed |
| EP-1543324-A2 | METHODS AND COMPOSITIONS FOR GRAFTING FUNCTIONAL LOOPS INTO A PROTEIN | GENENCOR INTERNATIONAL, INC. (US) | 2005-06-22 | — | — | EP | disclosed |
| WO-2003105757-A2 | METHODS AND COMPOSITIONS FOR MILIEU-DEPENDENT BINDING OF A TARGETED AGENT TO A TARGET | GENENCOR INTERNATIONAL, INC. (US) | 2003-12-24 | — | — | WO | disclosed |
| EP-1341908-A2 | TARGETED ENZYME PRODRUG THERAPY | GENENCOR INTERNATIONAL, INC. (US) | 2003-09-10 | — | — | EP | disclosed |
| EP-1341907-A2 | TARGET ENZYMES | GENENCOR INTERNATIONAL, INC. (US) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002047717-A9 | TARGETED ENZYME PRODRUG THERAPY | GENENCOR INT (US) | 2003-05-30 | — | — | WO | disclosed |
| WO-2002048372-A2 | TARGET ENZYMES | GENENCOR INTERNATIONAL, INC. (US) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002047717-A2 | TARGETED ENZYME PRODRUG THERAPY | GENENCOR INTERNATIONAL, INC. (US) | 2002-06-20 | — | — | WO | disclosed |
| EP-0575556-A4 | PALYTOXIN-RELATED PRODRUGS AND A METHOD FOR THEIR ADMINISTRATION. | HAWAII BIOTECH GROUP (US) | 1994-03-21 | — | — | EP | disclosed |
| EP-0575556-A1 | PALYTOXIN-RELATED PRODRUGS AND A METHOD FOR THEIR ADMINISTRATION | HAWAII BIOTECHNOLOGY GROUP, INC. (US) | 1993-12-29 | — | — | EP | disclosed |
| WO-1992016203-A1 | PALYTOXIN-RELATED PRODRUGS AND A METHOD FOR THEIR ADMINISTRATION | HAWAII BIOTECHNOLOGY GROUP, INC. (US) | 1992-10-01 | — | — | WO | disclosed |
| EP-0320785-A2 | Peptides influencing the activity of the hypophysis of mammalians | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-06-21 | — | — | EP | disclosed |